“The results show that chronic treatment … neurons with tyrosine kinase inhibitor genistein ) resulted in downregulation … NR2B subunit polypeptide levels, while daidzein, an inactive analog of genistein, did not alter the levels of NR2B subunit, … that tyrosine kinases may be involved in the regulation of the NMDA NR2B subunit content.”